Ohio Public Employees Retirement System (OPERS)’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-26,094
Closed -$468K 2373
2025
Q1
$468K Sell
26,094
-76,662
-75% -$1.56M ﹤0.01% 1492
2024
Q4
$1.79M Buy
102,756
+51,876
+102% +$918K 0.01% 1180
2024
Q3
$712K Hold
50,880
﹤0.01% 1323
2024
Q2
$418K Buy
50,880
+50,100
+6,423% +$337K ﹤0.01% 1290
2024
Q1
$6.01K Sell
780
-51,126
-98% -$431K ﹤0.01% 1911
2023
Q4
$467K Sell
51,906
-3,900
-7% -$28.4K ﹤0.01% 1280
2023
Q3
$499K Hold
55,806
﹤0.01% 1243
2023
Q2
$857K Hold
55,806
﹤0.01% 1186
2023
Q1
$1.25M Hold
55,806
0.01% 1112
2022
Q4
$1.17M Sell
55,806
-12,667
-18% -$268K 0.01% 1126
2022
Q3
$1.69M Hold
68,473
0.01% 1082
2022
Q2
$1.66M Sell
68,473
-9,500
-12% -$239K 0.01% 1128
2022
Q1
$2.01M Hold
77,973
0.01% 1112
2021
Q4
$2.42M Hold
77,973
0.01% 1060
2021
Q3
$1.89M Buy
+77,973
New +$1.43M 0.01% 1137

Other funds holding TVTX

Ohio Public Employees Retirement System (OPERS)'s TVTX Position: Q2 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Travere Therapeutics (TVTX) in Q2 2025, closing a stake of 26,094 shares — an estimated $468K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in TVTX in Q3 2021 and held it in 15 quarters. The position peaked at $2.42M in Q4 2021. 211 funds tracked by Wall St. Rank hold TVTX as of Q2 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Travere Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 26,094 Travere Therapeutics shares in Q2 2025, an estimated $468K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Travere Therapeutics in Q3 2021 and held it in 15 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Travere Therapeutics position peaked at $2.42M in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2025, filed 15 Jul 2025.